These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9358550

  • 1. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.
    Pikal MJ, Rigsbee DR.
    Pharm Res; 1997 Oct; 14(10):1379-87. PubMed ID: 9358550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [Abstract] [Full Text] [Related]

  • 5. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY, Lin HL, Chi YT, Huang YT, Kao CY, Hsieh WH.
    Int J Pharm; 2015 Dec 30; 496(2):457-65. PubMed ID: 26481469
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, Rades T, Löbmann K.
    J Pharm Pharmacol; 2016 May 30; 68(5):615-24. PubMed ID: 26245703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D, Yin S, Pan D, Crull G, Timmins P, Vig B.
    Mol Pharm; 2017 Feb 06; 14(2):377-385. PubMed ID: 28068097
    [Abstract] [Full Text] [Related]

  • 13. Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state.
    Sharma VK, Kalonia DS.
    AAPS PharmSciTech; 2004 Feb 17; 5(1):E10. PubMed ID: 15198531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G, Nouri K, Grohganz H, Rades T, Löbmann K.
    Int J Pharm; 2017 Nov 25; 533(1):138-144. PubMed ID: 28947246
    [Abstract] [Full Text] [Related]

  • 18. Effects of types of sugar on the stabilization of protein in the dried state.
    Imamura K, Ogawa T, Sakiyama T, Nakanishi K.
    J Pharm Sci; 2003 Feb 25; 92(2):266-74. PubMed ID: 12532376
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM, Truong-Le V, Yee L, Pan E, Ao Y, Kalonia DS, Pikal MJ.
    Pharm Res; 2007 Apr 25; 24(4):715-27. PubMed ID: 17372697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.